Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Animalcare Group delisted from AIM after takeover by Charterhouse subsidiary

The shares of Animalcare Group were removed from trading on the AIM of the London Stock Exchange on Wednesday morning after CCP PAW 2 Limited — a 100% subsidiary of funds managed/advised by Charterhouse Capital Partners — acquired the company via a scheme of arrangement under Part 26 of the Companies Act 2006. The scheme took effect on Wednesday; Animalcare plans to convert into a private limited company. Financial and legal advisers on the transaction included Rothschild & Co, Stifel Nicolaus Europe, Panmure Liberum, Allen & Overy and Squire Patton Boggs. » More on de.investing.com
Animalcare Group issues 967,954 new shares after option exercise

Following court approval of the takeover scheme and the exercise of outstanding options, Animalcare Group has issued 967,954 new ordinary shares. The exercise followed the takeover announcement by CCP PAW 2 Limited (Charterhouse) and rendered the options vested and exercisable under Rule 15 of the Takeover Code. The new shares are expected to be admitted to trading on AIM on Tuesday at around 08:00; issued share capital rises to 70,013,899 shares of 20 pence each. CEO Jennifer Winter received 468,797 shares (total 569,447; 0.81%) and CFO Christopher Brewster 188,384 shares (total 473,897; 0.68%). » More on de.investing.com
JPMorgan increases stake in Animalcare Group to 6.356%

JPMorgan Chase & Co. has increased its voting stake in the Animalcare Group to 6.356% and now holds 4,388,686 voting rights. The position comprises 6.351% direct share voting rights via J.P. Morgan Securities PLC and 0.005% through cash-settled equity swaps with maturities to November 2026 and July 2027. The notification was made in accordance with UK disclosure requirements. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2025, ANIMALCARE GROUP has already paid €0.0595 in dividends. The last payout was in November 2025.

Financials

In the last quarter, ANIMALCARE GROUP had revenue of €51.98m and net profit of €2.08m

(EUR)	December 2025	YoY
Revenue	51.98m	-
Gross profit	25.51m	-
Net profit	2.08m	-
EBITDA	9.3m	-

Fundamentals

Metric	Value
Market capitalization	€277.3m
Number of shares	69.05m
52-week high/low	€4.08 - €2.59
Dividend yield	0.64%
Dividends TTM	€0.0249
Beta	0.67
P/E ratio	45.39
PEG ratio	-0.53
P/B ratio	2.02
P/S ratio	2.60

Company profile

Animalcare Group plc engages in the development, sale, and distribution of licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets. It is also involved in the wholesale and marketing of veterinary pharmaceuticals. The company serves customers in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, other European countries, Asia, the Middle East, Africa, and internationally. Animalcare Group plc was incorporated in 1972 and is based in York, the United Kingdom.